British Horseracing Authority Enhances Testing to Combat Gene Doping in Racehorses

The British Horseracing Authority (BHA) has allocated nearly two million pounds to research improving gene doping detection in racehorses and has integrated testing into regular procedures. This move aims to protect horse welfare and the integrity of thoroughbred racing amid potential gene manipulation threats from scientific and technological advances.

The British Horseracing Authority (BHA) is taking decisive action against gene doping in British racehorses, announcing a major investment aimed at improving detection. Nearly two million pounds ($2.59 million) have been directed towards research that will refine testing methods.

New procedures will see gene doping tests becoming a regular part of both race day and out-of-competition sampling processes, implemented with immediate effect. According to Brant Dunshea, BHA's acting chief executive, this initiative underscores a strong commitment to the welfare of racehorses.

Though there is no current evidence of genetic manipulation within British or international horse racing, the BHA stresses the increasing threat posed by scientific advancements enabling genetic modification. Such practices, involving gene editing or transfers, risk altering the integrity and essence of thoroughbred breeds.

(With inputs from agencies.)